Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Spermine: Natural Iron Chelator Prevents Ferroptosis

June 3, 2026
Continue Reading
spermine:-natural-iron-chelator-prevents-ferroptosis
Posted inBiotechnology

Barriers to Rapid Fever Test Use in Africa

June 3, 2026
Continue Reading
barriers-to-rapid-fever-test-use-in-africa
Posted inBiotechnology

Acridine Compound Binds VEGF, Cuts CAM Vascularization

June 3, 2026
Continue Reading
acridine-compound-binds-vegf,-cuts-cam-vascularization
Posted inBiotechnology

Geriatric Assessments Boost Outcomes, Cut Costs in Thailand

June 3, 2026
Continue Reading
geriatric-assessments-boost-outcomes,-cut-costs-in-thailand
Posted inBiotechnology

On-Demand Nanomanufacturing of Electronics in Microgravity

June 3, 2026
Continue Reading
on-demand-nanomanufacturing-of-electronics-in-microgravity
Posted inBiotechnology

Even “Safe” Air Pollution Levels Pose Health Risks

June 3, 2026
Continue Reading
even-“safe”-air-pollution-levels-pose-health-risks
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

astellas-pays-sangamo-$20m-upfront-to-improve-neurological-gene-therapy-capabilities
Posted inBiotechnology

Astellas pays Sangamo $20M upfront to improve neurological gene therapy capabilities

December 19, 2024
Astellas is continuing to strengthen its neurological disease gene therapy capabilities, handing Sangamo Therapeutics $20 million upfront to help bypass…
Read More
akamis-bio-raises-$60-million-for-cancer-gene-therapy,-signs-licensing-deal-with-xuanzhu-biopharma
Posted inGenetics

Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma

December 19, 2024
Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of…
Read More
mechanisms-underlying-sjogren’s-disease-outlined-in-mice;-existing-drug-shows-therapeutic-promise
Posted inGenetics

Mechanisms Underlying Sjögren’s Disease Outlined in Mice; Existing Drug Shows Therapeutic Promise

December 19, 2024
Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice…
Read More
how-fungi-make-a-promising-compound-for-treating-cancer-and-inflammation
Posted inGenetics

How Fungi Make a Promising Compound for Treating Cancer and Inflammation

December 18, 2024
The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is…
Read More
xgen-venture-closes-$190m-fund-with-plans-to-invest-in-early-stage-biotech,-medtech-firms
Posted inBiotechnology

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms

December 18, 2024
Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. The life…
Read More
labcorp-launches-bird-flu-test-amid-first-severe-case-in-the-us
Posted inMedical Technology

Labcorp launches bird flu test amid first severe case in the US

December 18, 2024
Amid reports of the first severe human case of bird flu in the U.S., Labcorp has launched a molecular diagnostic…
Read More
the-state-of-cell-and-gene-therapy-2025
Posted inGenetics

The State of Cell and Gene Therapy 2025

December 18, 2024
Broadcast Date:  Wednesday, January 29, 2025Time:  8:00 am PT, 11:00 am ET, 17:00 CET The field of cell and gene…
Read More
alphabet-spinoff-sandboxaq-raises-$300m-fund-for-‘next-wave-of-ai’
Posted inBiotechnology

Alphabet spinoff SandboxAQ raises $300M fund for ‘next wave of AI’

December 18, 2024
Alphabet spinoff SandboxAQ has raised more than $300 million to go toward developing AI applications across multiple areas including drug…
Read More
lawsuit-accuses-applied-therapeutics-of-misleading-investors-before-fda-rejection
Posted inBiotechnology

Lawsuit accuses Applied Therapeutics of misleading investors before FDA rejection

December 18, 2024
After its rare disease drug was rejected by the FDA in late November, Applied Therapeutics vowed to fight on with…
Read More
editor’s-corner:-fierce-biotech’s-10-most-read-stories-of-2024
Posted inBiotechnology

Editor’s Corner: Fierce Biotech’s 10 most-read stories of 2024

December 18, 2024
For the end of this year, Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting.…
Read More

Posts pagination

Previous page 1 … 1,903 1,904 1,905 1,906 1,907 … 1,916 Next page
You May Have Missed
imu-biosciences-nabs-$53m-funding-round-to-‘decode’-the-immune-system
Posted inMedical Technology

IMU Biosciences nabs $53M funding round to ‘decode’ the immune system

foundation-medicine-tallies-fda-nod-to-pair-its-blood-test-with-pfizer’s-prostate-cancer-combo
Posted inMedical Technology

Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo

mindmaze-therapeutics-culls-program,-ends-legacy-ops-from-relief-merger-to-cut-costs
Posted inMedical Technology

MindMaze Therapeutics culls program, ends legacy ops from Relief merger to cut costs

human-longevity-launches-newco,-teams-with-insilico-for-ai-powered-longevity-research
Posted inMedical Technology

Human Longevity launches newco, teams with Insilico for AI-powered longevity research

Privacy Policy    Terms

Scroll to Top